Management of Atherosclerotic Aortoiliac Occlusive Disease
Marcin Bujak1, Jacqueline Gamberdella1, Carlos Mena1
1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street, DANA3 Cardiology, New Haven, CT 06510, USA.
Insights
Aortoiliac occlusive disease (AIOD) management focuses on risk factors and preventing cardiovascular events. Less invasive endovascular techniques are increasingly replacing traditional surgical interventions for AIOD.
Area of Science:
- Vascular Surgery
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Aortoiliac occlusive disease (AIOD) is linked to traditional atherosclerotic risk factors like hyperlipidemia, hypertension, diabetes, and smoking.
- Current AIOD management prioritizes risk factor modification, smoking cessation, and cardiovascular event prevention.
- Symptom relief and limb salvage are secondary therapeutic objectives in AIOD.
Purpose of the Study:
- To review the evolving landscape of AIOD management.
- To highlight the shift from traditional surgical approaches to contemporary endovascular techniques.
- To underscore the impact of technological advancements on AIOD treatment strategies.
Main Methods:
- Review of current literature on AIOD management.
- Analysis of the evolution of surgical versus endovascular interventions.
- Discussion of technological innovations in revascularization techniques.
Main Results:
- Risk factor modification and cardiovascular event prevention remain primary goals in AIOD.
- Endovascular techniques and devices are increasingly adopted for AIOD treatment.
- Technological advancements are continuously reshaping AIOD management strategies.
Conclusions:
- The management of AIOD is dynamic, driven by technological progress.
- Endovascular approaches are becoming the preferred method for AIOD revascularization.
- A shift from open surgery to less invasive endovascular techniques is evident in AIOD care.
Abstract:
Development of aortoiliac occlusive disease (AIOD) is associated with classic risk factors for atherosclerotic disease such as hyperlipidemia, hypertension, diabetes, or smoking. Risk factor modification, smoking cessation, and prevention of cardiovascular events remain the cornerstones of AIOD management. Symptom improvement and limb loss prevention are considered secondary goals of therapy. Continuous technological advances, new devices, as well as new revascularization techniques are constantly changing the landscape of AIOD management. Surgical interventions, which were considered a gold standard therapy for nearly 50 years, currently give way to newer and less invasive endovascular techniques.
Related Concept Videos
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Aneurysm III: Interprofessional Care
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease IV: Nursing Management

